What did @leonamwah actually say?
Honestly? Not much, medically speaking. The transcript here is song lyrics, not health claims. "Can you keep up? Baby boy, it feels my breath" is almost certainly audio from a track playing over a transition or lifestyle video. There are no direct claims about hormones, TRT, or any treatment protocol in the spoken words. The video's medical relevance comes entirely from how it was categorized and the hashtag context, not from anything the creator said out loud.
That said, the hashtags tell a story. Terms like #mtftrans and #transgirl place this squarely in the gender-affirming hormone therapy (GAHT) space. For a platform categorizing this under TRT, that's worth unpacking, because feminizing hormone therapy and testosterone replacement therapy for hypogonadism are not the same clinical intervention, even when they both involve sex hormones.
Does the science back this up?
Since there are no direct medical claims to evaluate, the more useful question is: what does science actually say about hormone therapy in trans women? The short answer is that the evidence base has grown substantially over the past decade, but it is still not on par with the decades of cisgender HRT research.
A 2021 review by Iwamoto et al. in Andrology confirmed that estrogen-based GAHT reliably suppresses endogenous testosterone and produces feminizing physical changes over months to years. The same review noted that cardiovascular and thromboembolic risk, particularly with estradiol valerate versus estradiol, remains a clinically significant concern requiring monitoring. Separate work by Nota et al. (2019, Circulation) found elevated stroke and VTE risk in trans women on oral estrogens, reinforcing that route of administration matters. These are not fringe findings. Any platform touching this category needs to engage with them.
What did they get wrong (or right)?
Credit where it is due: the creator did not make a single misleading medical claim. There is nothing to correct in the transcript, because the transcript contains no medical content. That is actually fine. Not every piece of content needs to be educational to be valid.
What does deserve scrutiny is the category assignment. Grouping a gender-affirming lifestyle video under "TRT for hypogonadism and hormone optimization" flattens a real clinical distinction. Trans women undergoing GAHT are typically pursuing estradiol plus an anti-androgen, not testosterone. Framing this under TRT risks confusing two populations with genuinely different protocols, monitoring needs, and risk profiles. The American Endocrine Society's 2017 clinical practice guidelines (Hembree et al., Journal of Clinical Endocrinology and Metabolism) treat these as distinct clinical categories for a reason.
What should you actually know?
If you are a trans woman considering or currently on GAHT, here is what the evidence actually supports. Feminizing hormone therapy typically involves estradiol, delivered transdermally or by injection, combined with an anti-androgen such as spironolactone or bicalutamide. Oral estradiol carries higher clotting risk than transdermal routes, a point confirmed by multiple studies including Getahun et al. (2018, Annals of Epidemiology).
Baseline labs before starting, including a lipid panel, liver function, and hematocrit, are standard of care. Ongoing monitoring every 3 to 6 months in the first year is recommended by both the Endocrine Society and WPATH. If you are seeking care through a telehealth platform, confirm they follow these guidelines. "Hormone optimization" language that downplays monitoring is a red flag, not a feature.
- Estradiol route matters: transdermal reduces VTE risk compared to oral formulations
- Anti-androgens like spironolactone require potassium and blood pressure monitoring
- Changes take time: breast development, fat redistribution, and skin changes typically take 1 to 3 years
- Fertility effects may be partially irreversible; banking options should be discussed before starting